Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
96.66
+4.57 (4.96%)
At close: Mar 9, 2026, 4:00 PM EDT
96.27
-0.39 (-0.40%)
After-hours: Mar 9, 2026, 7:45 PM EDT
Protagonist Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -130.15 | 275.19 | -78.96 | -127.39 | -125.55 | |
| Depreciation & Amortization | 1.28 | 2.9 | 3.31 | 3.37 | 2.78 | |
| Loss (Gain) From Sale of Investments | -7.22 | -8.88 | -4.57 | -0.55 | 1.83 | |
| Stock-Based Compensation | 45.97 | 37.55 | 29.29 | 24.2 | 16.4 | |
| Other Operating Activities | 1.58 | - | 0.19 | - | - | |
| Change in Accounts Receivable | 164.88 | -155 | -9.99 | 1.56 | 0.86 | |
| Change in Accounts Payable | 3.72 | 0.84 | -2.87 | 2.05 | -1.39 | |
| Change in Unearned Revenue | -21.02 | 30.57 | - | -1.6 | -12.88 | |
| Change in Income Taxes | -2.69 | 2.69 | - | - | - | |
| Change in Other Net Operating Assets | 1.31 | -1.71 | -6.65 | -9.77 | 10.09 | |
| Operating Cash Flow | 57.67 | 184.15 | -70.24 | -108.14 | -107.87 | |
| Operating Cash Flow Growth | -68.68% | - | - | - | - | |
| Capital Expenditures | -1.59 | -1.36 | -0.61 | -0.8 | -1.1 | |
| Investment in Securities | -47.74 | -298.13 | -38.65 | 92.26 | -14.76 | |
| Investing Cash Flow | -49.33 | -299.48 | -39.26 | 91.47 | -15.86 | |
| Issuance of Common Stock | 23.34 | 26.45 | 171.25 | 19 | 130.11 | |
| Repurchase of Common Stock | -0.48 | -0.6 | -0.77 | -0.19 | -0.19 | |
| Other Financing Activities | - | - | - | 0.03 | - | |
| Financing Cash Flow | 22.86 | 25.85 | 170.48 | 18.84 | 129.92 | |
| Foreign Exchange Rate Adjustments | - | - | - | -0.09 | -0.13 | |
| Net Cash Flow | 31.2 | -89.48 | 60.98 | 2.08 | 6.07 | |
| Free Cash Flow | 56.08 | 182.8 | -70.85 | -108.93 | -108.97 | |
| Free Cash Flow Growth | -69.32% | - | - | - | - | |
| Free Cash Flow Margin | 121.87% | 42.08% | -118.08% | -409.81% | -398.31% | |
| Free Cash Flow Per Share | 0.88 | 2.81 | -1.25 | -2.22 | -2.35 | |
| Cash Income Tax Paid | 3.69 | 1.53 | - | - | - | |
| Levered Free Cash Flow | 105.62 | 65.11 | -43.31 | -60.37 | -61.59 | |
| Unlevered Free Cash Flow | 105.62 | 65.11 | -43.31 | -60.37 | -61.59 | |
| Change in Working Capital | 146.21 | -122.61 | -19.51 | -7.77 | -3.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.